GNS Q4 2022 Earnings Massive EPS Miss as Reported Loss Exceeds Estimates by Wide Margin TAC Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Persist Ernexa Therapeutics Inc ERNA Q3 2023 Earnings Narrowing Losses Amidst Pipeline Progress HuBS Q1 2026 Earnings EPS Beats Estimates by 809 as Stock Declines Intensity Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Clinical Progress Modular Medical Q3 2025 Earnings Deeperthanexpected loss as stock rises 458